# OnCo record swog-9346 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/swog-9346/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "swog-9346", "NCT00002651" ;
  schema:name "SWOG 9346 (intermittent androgen deprivation)"@en ;
  schema:alternateName "SWOG 9346"@en, "S9346"@en, "INT-0162"@en ;
  schema:description "Taking breaks from hormone therapy for metastatic prostate cancer improved sex life and mood for a few months, but the trial could not rule out that it shortens life, so continuous treatment remained the standard."@en ;
  schema:url <https://onco.cc/trials/swog-9346/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00002651>, <https://doi.org/10.1056/NEJMoa1212299> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:companies <https://onco.cc/companies/swog/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/hormone-therapy/>, <https://onco.cc/terms/qol-pro/>, <https://onco.cc/terms/psa/> ;
  onco:trials <https://onco.cc/trials/chaarted/>, <https://onco.cc/trials/patch-transdermal-oestradiol/> .
